However, there have not yet been any well-controlled clinical trials that establish the link between GLP-1 drugs and preventing cancer
Studies tell us patients using the medications can lose up to 20% of their body weight depending on which medication is used and other lifestyle factors
Regular GP or specialist review is essential to monitor weight, blood glucose, HbA1c, and other metabolic parameters
This hormone is responsible for regulating blood sugar, insulin secretion, and appetite
The same study also showed more people on Tirzepatide hitting large weight-loss milestones ( 15 %, 20 %, even 25 % of body weight) compared with Semaglutide
Los resultados deben interpretarse junto con las caractersticas de los participantes, la dosis utilizada, los efectos adversos y el tiempo de seguimiento